MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-CH-01-0009868
Market Cap
₹17.15 Cr
ZENLABS · BSE
Share Price
₹26.95
+2.32% today
Revenue
₹46.92 Cr
FY 2025-26 · -8.8% YoY
EBITDA
−₹0.29 Cr
Margin -0.6%
Net Profit
₹0.03 Cr
FY 2025-26 · -88.9% YoY
ROE
0.2%
ROCE 4.7%
Debt / Equity
1.25
Interest cover -68.6x
Authorised capital
₹20 Cr
Registered with MCA
About Zenlabs Ethica Limited
Data last updated:
Zenlabs Ethica Limited is a public limited company based in Chandigarh, India. It operates in the non-banking financial services (NBFC) segment of the financial services sector. It was incorporated on 20 July 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN L74900CH1993PLC033112. The company has 1 GST registration on record, which is no longer active. It is a listed company as per MCA records. Its shares are listed on BSE: 530697.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹6.51 Cr. It was formerly known as Shri Lakhavi Infotech Limited and Neelkanth Technologies Limited. It is led by directors including Sanjeev Singal (Managing Director) and Sanjay Dhir (Whole-Time Director).
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Plot No. 194 – 195 3rd Floor Industrial Area Phase II Ram Darbar, Chandigarh, India – 160002.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹46.92 Cr, a decline of 8.8% compared to the previous year. For the same year it recorded a net profit of ₹3 Lakh (net margin 0.1%) and EBITDA of -₹29 Lakh (EBITDA margin -0.6%). The net worth stands at ₹8.51 Cr (down 18.4% YoY). Total assets are valued at ₹20.58 Cr (down 16.4% YoY).
The company has about 16 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Zenlabs. As per MCA filings, the company has open charges of ₹8.37 Cr on record. Court records list 8 cases involving the company, including 5 filed by the company and 3 filed against it; 2 cases are pending. The company has 29 deals on record (29 market trades); the latest was in March 2026. Its 3 peer companies in the BFSI industry (Formulations, NBFC Investment and Credit Companies, Small Non Deposit NBFC), with the same principal business activity (wholesale trading) are compared by revenue, 1 larger and 2 smaller; the largest is Junna Life Sciences Private Limited with revenue of ₹51.69 Cr. The company has 20 MSME Form 1 returns on record between 2019 and 2023, listing 3,041 overdue payments to 7 micro and small suppliers.
Zenlabs Ethica Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0009868). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zenlabsethica.com.
Company details
CIN L74900CH1993PLC033112
Registration Number 033112
Incorporation Date 20 July 1993
ROC Chandigarh
Listing Status Listed - Listed on BSE (530697)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-CH-01-0009868
Name history
Zenlabs Ethica has undergone 3 name changes throughout its history. The company was previously known as Shri Lakhavi Infotech Limited, Neelkanth Technologies Limited, and Shri Lakhavi Financial Services Limited. The current legal name is Zenlabs Ethica Limited.
| Company Name | Status |
|---|---|
| Zenlabs Ethica Limited | Current |
| Shri Lakhavi Infotech Limited | Previous |
| Neelkanth Technologies Limited | Previous |
| Shri Lakhavi Financial Services Limited | Previous |
CIN history
Zenlabs Ethica has 5 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L74900CH1993PLC033112, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L74900CH1993PLC033112 | Current |
| L65920CH1993PLC033112 | Previous |
| L65920MH1993PTC072999 | Previous |
| U65920MH1993PTC072999 | Previous |
| L65920MH1993PLC072999 | Previous |
| U65920MH1993PLC072999 | Previous |
Recognitions & Rankings of Zenlabs Ethica
Contact details
Zenlabs Ethica Limited's registered office is in Chandigarh, Chandigarh. Its website is zenlabsethica.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 194 – 195 3rd Floor Industrial Area Phase II Ram Darbar, Chandigarh, India – 160002
- IndustryFinancial Services, NBFC, Investment & Credit NBFC
To see the full contact details of Zenlabs Ethica Limited, buy the company report.
Comprehensive company report
Zenlabs Ethica Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Zenlabs Ethica operates one associated brand: Zenlabs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical drugs for multiple therapeutic areas are manufactured by Zenlabs. | zenlabsethica.com |
Business activity
The main business activity of Zenlabs Ethica is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Zenlabs Ethica Limited, buy the company report.
Financials of Zenlabs Ethica Limited
FY 2025-26 filings availableZenlabs Ethica Limited reported revenue of ₹46.92 Cr (down 8.8% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹46.92 Cr
-8.8% YoY
EBITDA
−₹0.29 Cr
-111.3% YoY
Profit After Tax
₹0.03 Cr
-88.9% YoY
Net Worth
₹8.51 Cr
-18.4% YoY
Total Assets
₹20.58 Cr
-16.4% YoY
Total Debt
₹10.98 Cr
-13.6% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 46.92 | 51.42 | 58.56 | 66.89 | 69.09 | 56.64 | 59.95 |
| Revenue growth | -8.8% | -12.2% | -12.5% | -3.2% | +22.0% | -5.5% | - |
| EBITDA | (0.29) | 2.57 | 2.40 | 2.34 | 2.41 | 1.73 | (0.70) |
| EBITDA margin | -0.6% | +5.0% | +4.1% | +3.5% | +3.5% | +3.1% | -1.2% |
| Profit before tax | (1.81) | 0.43 | 0.58 | 0.69 | 1.24 | 0.85 | (1.17) |
| Net profit | 0.03 | 0.27 | 0.42 | 0.92 | 0.80 | 0.77 | (0.74) |
| Net profit margin | +0.1% | +0.5% | +0.7% | +1.4% | +1.2% | +1.4% | -1.2% |
| EPS (₹) | (2.97) | 0.41 | 0.65 | 0.75 | 1.20 | 1.18 | (1.13) |
| Balance sheet | |||||||
| Total assets | 20.58 | 24.63 | 26.50 | 16.86 | 14.51 | 11.45 | 8.51 |
| Net worth | 8.51 | 10.43 | 10.12 | 9.70 | 9.33 | 8.56 | 7.41 |
| Total debt | 10.98 | 12.71 | 14.86 | 5.85 | 3.90 | 2.60 | 0.73 |
| Cash & bank | 2.91 | 1.80 | 0.93 | 1.64 | 1.51 | 1.70 | 2.09 |
| Net working capital | 18.47 | 21.37 | 21.80 | 10.87 | 10.03 | 6.74 | 6.34 |
| Cash flow | |||||||
| Cash from operations | 4.06 | 3.83 | (9.06) | 1.52 | (0.38) | (8.41) | 0.45 |
| Cash from investing | 0.00 | 0.14 | 0.11 | (1.47) | 0.00 | 0.15 | 0.01 |
| Cash from financing | (2.95) | (3.08) | 8.24 | 0.06 | 0.31 | (0.52) | (0.03) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.18 | 10.58 | 12.43 | 12.43 | 11.48 | 12.99 | 12.72 | 13.35 |
| Revenue growth (YoY) | +23.5% | -18.6% | -2.3% | -6.9% | -7.1% | - | - | - |
| Other income | 0.00 | 0.12 | 0.00 | 0.06 | 0.00 | 0.04 | 0.00 | 0.00 |
| Total expenses | 14.47 | 10.30 | 13.99 | 11.99 | 10.93 | 12.33 | 12.04 | 12.73 |
| EBITDA | (0.29) | 0.28 | (1.56) | 0.44 | 0.55 | 0.66 | 0.68 | 0.62 |
| EBITDA margin | -2.0% | +2.6% | -12.6% | +3.5% | +4.8% | +5.1% | +5.3% | +4.6% |
| Depreciation | 0.11 | 0.14 | 0.23 | 0.24 | 0.29 | 0.31 | 0.32 | 0.31 |
| Interest | 0.16 | 0.18 | 0.23 | 0.19 | 0.21 | 0.23 | 0.24 | 0.23 |
| Profit before tax | (0.56) | 0.08 | (2.02) | 0.07 | 0.05 | 0.16 | 0.12 | 0.08 |
| Tax | 0.02 | 0.08 | 0.00 | 0.04 | 0.01 | 0.07 | 0.04 | 0.02 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 24 Oct 2026
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.18 | 10.58 | 12.43 | 12.43 | 11.48 | 12.99 | 12.72 | 13.35 |
| Revenue growth (YoY) | +23.5% | -18.6% | -2.3% | -6.9% | -7.1% | - | - | - |
| Other income | 0.00 | 0.12 | 0.00 | 0.06 | 0.00 | 0.04 | 0.00 | 0.00 |
| Total expenses | 14.47 | 10.30 | 13.99 | 11.99 | 10.93 | 12.33 | 12.04 | 12.73 |
| EBITDA | (0.29) | 0.28 | (1.56) | 0.44 | 0.55 | 0.66 | 0.68 | 0.62 |
| EBITDA margin | -2.0% | +2.6% | -12.6% | +3.5% | +4.8% | +5.1% | +5.3% | +4.6% |
| Depreciation | 0.11 | 0.14 | 0.23 | 0.24 | 0.29 | 0.31 | 0.32 | 0.31 |
| Interest | 0.16 | 0.18 | 0.23 | 0.19 | 0.21 | 0.23 | 0.24 | 0.23 |
| Profit before tax | (0.56) | 0.08 | (2.02) | 0.07 | 0.05 | 0.16 | 0.12 | 0.08 |
| Tax | 0.02 | 0.08 | 0.00 | 0.04 | 0.01 | 0.07 | 0.04 | 0.02 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 46.92 | 51.42 | 58.56 | 66.89 | 69.09 | 56.64 | 59.95 |
| Revenue growth | -8.8% | -12.2% | -12.5% | -3.2% | +22.0% | -5.5% | - |
| Other income | 0.18 | 0.05 | 0.30 | 0.13 | 0.09 | 0.12 | 0.05 |
| Total expenses | 47.21 | 48.85 | 56.16 | 64.55 | 66.68 | 54.91 | 60.65 |
| Employee cost | 4.17 | 4.20 | 4.46 | 4.33 | 3.90 | 3.42 | 3.24 |
| EBITDA | (0.29) | 2.57 | 2.40 | 2.34 | 2.41 | 1.73 | (0.70) |
| EBITDA margin | -0.6% | +5.0% | +4.1% | +3.5% | +3.5% | +3.1% | -1.2% |
| Depreciation | 0.89 | 1.26 | 1.29 | 1.25 | 0.89 | 0.71 | 0.29 |
| Interest | 0.81 | 0.93 | 0.83 | 0.53 | 0.37 | 0.29 | 0.23 |
| Profit before tax | (1.81) | 0.43 | 0.58 | 0.69 | 1.24 | 0.85 | (1.17) |
| Tax | 0.12 | 0.16 | 0.16 | 0.18 | 0.44 | 0.09 | (0.43) |
| Net profit | 0.03 | 0.27 | 0.42 | 0.92 | 0.80 | 0.77 | (0.74) |
| Net profit margin | +0.1% | +0.5% | +0.7% | +1.4% | +1.2% | +1.4% | -1.2% |
| EPS (₹) | (2.97) | 0.41 | 0.65 | 0.75 | 1.20 | 1.18 | (1.13) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 6.51 | 6.51 | 6.51 | 6.51 | 6.51 | 6.51 | 6.51 |
| Reserves & surplus | 2.00 | 3.92 | 3.61 | 3.19 | 2.82 | 2.05 | 0.90 |
| Shareholders' funds (net worth) | 8.51 | 10.43 | 10.12 | 9.70 | 9.33 | 8.56 | 7.41 |
| Secured loans | 8.78 | 11.23 | 12.34 | 2.67 | 1.36 | 0.38 | 0.32 |
| Unsecured loans | 2.20 | 1.48 | 2.52 | 3.18 | 2.54 | 2.22 | 0.41 |
| Total debt | 10.98 | 12.71 | 14.86 | 5.85 | 3.90 | 2.60 | 0.73 |
| Total liabilities | 20.58 | 24.63 | 26.50 | 16.86 | 14.51 | 11.45 | 8.51 |
| Assets | |||||||
| Gross block | 4.65 | 8.82 | 9.12 | 9.16 | 6.41 | 5.50 | 2.29 |
| Net block | 1.87 | 2.29 | 3.69 | 5.03 | 3.53 | 3.51 | 1.12 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.70 | 0.70 | 0.70 | 0.70 | 0.70 | 0.70 |
| Inventories | 15.01 | 13.10 | 12.00 | 11.37 | 8.66 | 5.18 | 4.60 |
| Sundry debtors | 15.70 | 19.54 | 20.73 | 21.70 | 20.74 | 18.88 | 22.24 |
| Cash & bank balances | 2.91 | 1.80 | 0.93 | 1.64 | 1.51 | 1.70 | 2.09 |
| Loans & advances | 1.48 | 2.92 | 1.89 | 2.80 | 2.50 | 1.73 | 2.89 |
| Total current assets | 35.10 | 37.36 | 35.55 | 37.51 | 33.41 | 27.49 | 31.82 |
| Total current liabilities | 16.63 | 15.99 | 13.75 | 26.64 | 23.38 | 20.75 | 25.48 |
| Net working capital | 18.47 | 21.37 | 21.80 | 10.87 | 10.03 | 6.74 | 6.34 |
| Total assets | 20.58 | 24.63 | 26.50 | 16.86 | 14.51 | 11.45 | 8.51 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 1.79 | 0.91 | 1.62 | 1.51 | 1.57 | 10.35 | 1.67 |
| Net cash from operating activities | 4.06 | 3.83 | (9.06) | 1.52 | (0.38) | (8.41) | 0.45 |
| Net cash from investing activities | 0.00 | 0.14 | 0.11 | (1.47) | 0.00 | 0.15 | 0.01 |
| Net cash from financing activities | (2.95) | (3.08) | 8.24 | 0.06 | 0.31 | (0.52) | (0.03) |
| Net change in cash | 1.11 | 0.88 | (0.71) | 0.11 | (0.07) | (8.78) | 0.43 |
| Closing cash | 2.91 | 1.80 | 0.93 | 1.64 | 1.51 | 1.70 | 2.09 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -8.8% | -12.2% | -12.5% | -3.2% | +22.0% | -5.5% | - |
| EBITDA growth | -111.3% | +7.1% | +2.6% | -2.9% | +39.3% | +347.1% | - |
| PBT growth | - | -25.9% | -15.9% | -44.4% | +45.9% | +9998.0% | - |
| Net income growth | -88.9% | -35.7% | -54.4% | +15.0% | +3.9% | +204.1% | - |
| Revenue CAGR (3Y) | -11.2% | -9.4% | +1.1% | +3.7% | +0.9% | -7.6% | -9.6% |
| EBITDA CAGR (3Y) | - | +2.2% | +11.5% | - | +5.9% | -2.2% | - |
| Profitability & leverage | |||||||
| Net income margin | -4.1% | +0.5% | +0.7% | +0.8% | +1.2% | +1.3% | -1.2% |
| Return on capital employed | +4.7% | +5.3% | +6.5% | +11.4% | +12.3% | +11.5% | -10.7% |
| Return on net worth | +0.2% | +2.6% | +4.2% | +9.5% | +8.7% | +9.6% | -9.3% |
| Debt / equity | 1.25 | 1.34 | 1.04 | 0.51 | 0.36 | 0.21 | 0.08 |
| Long-term debt / equity | 0.06 | 0.11 | 0.23 | 0.27 | 0.22 | 0.14 | 0.04 |
| Interest cover | -68.64 | 70.99 | 74.77 | 48.62 | 24.34 | 28.43 | -23.23 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 6.97 | 5.73 | 6.41 | 8.59 | 11.60 | 14.54 | 26.47 |
| Inventory turnover | 3.34 | 4.10 | 5.01 | 6.68 | 9.98 | 11.58 | 13.25 |
| Debtors turnover | 2.66 | 2.55 | 2.76 | 3.15 | 3.49 | 2.75 | 2.54 |
| EPS (₹) | (2.97) | 0.41 | 0.65 | 0.75 | 1.20 | 1.18 | (1.13) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 13.08 | 16.01 | 15.55 | 14.91 | 14.34 | 13.16 | 11.38 |
To see the full year-wise statements and ratios of Zenlabs Ethica Limited, buy the company report.
Board of directors of Zenlabs Ethica Limited
Zenlabs Ethica has 5 current directors and 20 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Singal Also directs: Oasis Pharma and Phytomolecules Private Limited, Preet Remedies Limited, Ultra Chiron Healthcare Private Limited and 3 more | Managing Director | 27 Aug 2008 | 18 Years 1 Months | Current |
| Himjyoti Also directs: Quadriga Biotech Private Limited | Director | 25 Mar 2015 | 11 Years 6 Months | Current |
| Anurag Malhotra | Director | 11 Aug 2016 | 10 Years 2 Months | Current |
| Sanjay Dhir | Whole-Time Director | 11 Aug 2016 | 10 Years 2 Months | Current |
| Kuldeep Singh | Director | 10 Jun 2019 | 7 Years 4 Months | Current |
Peer comparison
Zenlabs Ethica Limited is compared with the 3 companies closest to it by revenue in the BFSI industry (Formulations, NBFC Investment and Credit Companies, Small Non Deposit NBFC), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Junna Life Sciences Private Limited | ₹51.69 Cr (FY 2025) | -25.0% | Hyderabad, Telangana, India | |||
| CNX Healthcare Private Limited | ₹51.46 Cr (FY 2025) | 24.0% | Mumbai, Maharashtra, India | |||
| KGN Pharmaceuticals Private Limited | ₹51.45 Cr (FY 2025) | 22.0% | Mumbai, Maharashtra, India | |||
| Zenlabs Ethica Limitedthis company | ₹46.92 Cr (FY 2026) | ₹3 Lakh | 0.1% | -8.8% | 16 | Chandigarh, India |
To see the full peer comparison of Zenlabs Ethica Limited, buy the company report.
Auditor
Zenlabs Ethica Limited is audited by N. Kumar Chhabra and Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N. Kumar Chhabra and Co. | FY 2023 | 000837N |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 53.00%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 47.00%.
Sep 2026
QUARTER
53.00% Promoters
47.00% Retail & Others
Promoter holding - history
Now 53.00% · Sep 2026High 53.00% · Dec 2025Low 53.00% · Dec 2025
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 53.00% | 53.00% | 53.00% | 53.00% |
| Public | 47.00% | 47.00% | 47.00% | 47.00% |
Charges & borrowings
Open charges
₹8.37 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Aug 2022 | 100606812 | Hdfc Bank Limited | ₹1.37 Cr | Open | |
| 26 Nov 2021 | 100508390 | Hdfc Bank Limited | ₹7 Cr | Open |
To see the full charge records of Zenlabs Ethica Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Zenlabs Ethica Limited has 29 deals on record (29 market trades); the latest was in March 2026.
Total deals
29
Market trades
29
Deals on record (5 of 29)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2026 | Market trade | ₹7.3 Lakh | Seller: an individual |
| Dec 2025 | Market trade | ₹13.2 Lakh | Buyer: an individual Seller: an individual |
| May 2019 | Market trade | ₹29 Lakh | Buyer: Alpha Leon Enterprises LLP Seller: Alpha Leon Enterprises LLP , an individual |
| Mar 2018 | Market trade | ₹44.9 Lakh | Buyer: Eco Recycling Limited Seller: an individual |
| Jan 2016 | Market trade | ₹3 Lakh | Seller: NBN Fintrade Private Limited |
To see the full deal history of Zenlabs Ethica Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Zenlabs Ethica Limited has 8 court cases on record: 5 filed by Zenlabs Ethica, 3 filed against it. 2 cases are pending and 6 are disposed.
Total cases
8
Filed by the company
5
Filed against the company
3
Pending
2
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 1 | 1 |
| District courts | 1 | 1 | 1 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed against the company by State Through Atish S Sarkale, Drug Inspector | Pending |
| High Court of Delhi | Writ petition | Filed by the company against Union of India & Anr. | Pending |
| High Court of Delhi | Commercial suit | Filed against the company by Glaxo Group Limited | Disposed |
| Supreme Court | Court case (1807-Ordinary Civil Matters : Others) | Filed against the company by Union of India Secretary Department of Health, A Wing, Nirman Bhavan, , District: New Delhi , , Delhi and 15 others | Disposed |
| High Court of Delhi | Writ petition | Filed by the company against Drugs Controller General of India & Anr. | Disposed |
To see the full case history of Zenlabs Ethica Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Zenlabs Ethica Limited has 20 MSME Form 1 returns on record between 2019 and 2023, listing 3,041 overdue payments to 7 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 7)
To see the full MSME payment records of Zenlabs Ethica Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Zenlabs Ethica Limited has a workforce of 16 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
16
Active EPFO establishments
1
Employee growth
-15.79%
GST
Zenlabs Ethica has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Zenlabs Ethica Limited, buy the company report.
Recent activity
Zenlabs Ethica Limited has 35 board changes on record since 1993: 20 appointments and 15 cessations. The latest: Akshay Saxena ceased to be Company Secretary on 19 Jul 2024.
Filing
Zenlabs Ethica Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Chandigarh.
AGM
Zenlabs Ethica Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Ceased
Akshay Saxena ceased to be Company Secretary.
Charges
A charge with Hdfc Bank Limited of Rs. 7.00 Cr registered on 26 Nov 2021 with Charge ID 100508390 was modified on 23 Jan 2024.
Ceased
Ashok Kumar Gupta ceased to be Director.
Ceased
Hitesh Popatlal Oswal ceased to be Additional Director.
Appointed
Akshay Saxena was appointed as Company Secretary.
Ceased
Tanvi Chhabra ceased to be Company Secretary.
Appointed
Hitesh Popatlal Oswal was appointed as Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.37 Cr with Charge ID 100606812 was registered on 24 Aug 2022.
Appointed
Tanvi Chhabra was appointed as Company Secretary.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.00 Cr with Charge ID 100508390 was registered on 26 Nov 2021.
29 earlier events are in the company report.
News
Frequently asked questions
Zenlabs Ethica is an active public limited company based in Chandigarh, India. The company works in nbfc, within the financial services industry. It was incorporated on 20 July 1993 (33+ years old) and is registered under CIN L74900CH1993PLC033112. Listed on BSE: 530697.
Zenlabs Ethica reported revenue of ₹46.92 Cr for FY 2025-26 (down 8.8% YoY) based on standalone financials.
Zenlabs Ethica has 5 current directors:
- Sanjeev Singal - Managing Director
- Sanjay Dhir - Whole-Time Director
- Himjyoti - Director
- Anurag Malhotra - Director
- Kuldeep Singh - Director
The latest financial statements of Zenlabs Ethica on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
No. Zenlabs Ethica has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Zenlabs Ethica is L74900CH1993PLC033112. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Zenlabs Ethica is a listed company as per MCA records. Its shares are listed on BSE (code: 530697).
Zenlabs Ethica has 8 court cases on record: 5 filed by the company and 3 filed against it. 2 are pending. Most are in the high courts.
Zenlabs Ethica was incorporated on 20 July 1993, making it 33+ years old. It is registered with the Registrar of Companies, Chandigarh.
Zenlabs Ethica has 29 deals on record (29 market trades); the latest was in March 2026.
The peers of Zenlabs Ethica by revenue are Junna Life Sciences Private Limited, CNX Healthcare Private Limited, KGN Pharmaceuticals Private Limited, all in the BFSI industry (Formulations, NBFC Investment and Credit Companies, Small Non Deposit NBFC), with the same principal business activity (wholesale trading).
Akshay Saxena ceased to be Company Secretary on 19 Jul 2024. Ashok Kumar Gupta ceased to be Director on 18 Oct 2023. Hitesh Popatlal Oswal ceased to be Additional Director on 30 Sep 2023. Zenlabs Ethica has 35 board changes on record in total.